newsfilter
← Latest News
Business Wire·

NeoGenomics to Participate in the 44th Annual J.P. Morgan Healthcare Conference

NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the Company will participate in the upcoming 44th Annual J.P. Morgan Healthcare